University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Training and Mentoring the Next Generation of Cancer Researchers and Providers

Training and Mentoring the Next Generation of Cancer Researchers and Providers

April 16, 2019

Led by Dr. Emily Bergsland, Associate Director of Education for the Helen Diller Family Comprehensive Cancer Center, the Office of Education & Training (OET) aims to connect the UCSF cancer community with education, mentoring, and career development opportunities across all trainee levels. We sat down ...
UCSF Study Aims to Increase Diversity in Cancer Clinical Trials

UCSF Study Aims to Increase Diversity in Cancer Clinical Trials

April 15, 2019

UC San Francisco is collaborating with the nonprofit Lazarex Cancer Foundation on a three-year study to identify ways to improve cancer clinical trial participation among medically underserved populations, including low-income individuals and racial and ethnic minorities.  The trial will launch this month at UCSF, followed ...
Medicaid Could Save $2.6 Billion Within a Year if Just 1 Percent of Recipients Quit Smoking

Medicaid Could Save $2.6 Billion Within a Year if Just 1 Percent of Recipients Quit Smoking

April 12, 2019

Reducing smoking, and its associated health effects, among Medicaid recipients in each state by just 1 percent would result in $2.6 billion in total Medicaid savings the following year, according to new research by UC San Francisco. The median state would save $25 million, ranging ...
Researchers Identify a New Therapeutic Target for Glioblastoma and Other Cancers

Researchers Identify a New Therapeutic Target for Glioblastoma and Other Cancers

April 11, 2019

UCSF researchers have discovered that STAG2 – a gene commonly mutated in several human cancers – plays an essential role in DNA replication, revealing potential mechanisms for therapeutically targeting glioblastoma and other cancers. As part of a multi-protein complex called cohesin, the STAG2 protein has been implicated ...
Cancer-Killing Combination Therapies Unveiled with New Drug-Screening Tool

Cancer-Killing Combination Therapies Unveiled with New Drug-Screening Tool

April 9, 2019

UC San Francisco scientists have designed a large-scale screen that efficiently identifies drugs that are potent cancer-killers when combined, but only weakly effective when used alone. Using this technique, the researchers eradicated a devastating blood cancer and certain solid tumor cells by jointly administering drugs ...
Sarah J. Nelson, PhD (1954-2019)

Sarah J. Nelson, PhD (1954-2019)

April 5, 2019

from Christopher P. Hess, MD, PhD Professor and Chair, Department of Radiology and Biomedical Imaging UCSF It is with a very heavy heart that I share with you that Sarah J. Nelson, PhD, luminary imaging scientist, friend, and long-time faculty member in the UCSF Department of ...